X. Eric Hu
Procter & Gamble
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by X. Eric Hu.
Journal of Organometallic Chemistry | 2002
Xuewei Liu; X. Eric Hu; Xinrong Tian; Adam W. Mazur; Frank H. Ebetino
Abstract Asymmetric Michael reaction of phosphinic or aminophosphinic acids with acrylate derivatives afforded phosphinyl dipeptidomimetics in excellent yields (>90%). Chiral induction of substituents at the α-position of acrylate derivatives of Evans oxazolidinone type auxiliaries was obtained in moderate to excellent diastereomeric and enantiomeric excesses (50–98%). Pure diastereomers and enantiomers of phosphinyl dipeptidomimetics 16 – 19 were also successfully separated by HPLC.
Tetrahedron Letters | 2002
X. Eric Hu
Abstract A piperidinyl aziridine underwent alcoholic nucleophilic addition with alcohols to result in corresponding trans 3-amino-4-substituted piperidines. The addition reaction was catalyzed by BF3·OEt2 in excellent regio- and stereoselectivity. The application of this method was extended to the addition of thiols, acids and halogens with sustained regio- and stereoselectivity.
Tetrahedron Letters | 2002
X. Eric Hu; Nick Kim; Benoit Ledoussal; Anny-Odile Colson
Abstract 3,4-Piperidinyl aziridine N -phosphonate underwent ring opening in Grignard addition catalyzed by a copper reagent to yield trans 3-amino-4-alkyl-piperidines. The nucleophilic addition occurred trans to the aziridine group and regioselectively at C-4 position of the piperidine ring. The high regioselectivity was rationalized by steric argument based on conformational analysis.
Bioorganic & Medicinal Chemistry Letters | 2003
Jeffrey Lyle Gray; Ji-In Kim Almstead; Corey P. Gallagher; X. Eric Hu; Nick Kim; Cynthia J. Taylor; Tracy L. Twinem; Cynthia D. Wallace; Benoit Ledoussal
Quinolones without the usual 6-fluorine substituent have been recently described as potent antibacterial agents. A series of non-fluorinated analogues of the antibacterial quinolone Levofloxacin were synthesized and tested.
Molecular Pharmacology | 2015
Jianye Zhang; Zhiqian Dong; Sreenivasa Reddy Mundla; X. Eric Hu; William Seibel; Ruben Papoian; Krzysztof Palczewski; Marcin Golczak
All-trans-retinal, a retinoid metabolite naturally produced upon photoreceptor light activation, is cytotoxic when present at elevated levels in the retina. To lower its toxicity, two experimentally validated methods have been developed involving inhibition of the retinoid cycle and sequestration of excess of all-trans-retinal by drugs containing a primary amine group. We identified the first-in-class drug candidates that transiently sequester this metabolite or slow down its production by inhibiting regeneration of the visual chromophore, 11-cis-retinal. Two enzymes are critical for retinoid recycling in the eye. Lecithin:retinol acyltransferase (LRAT) is the enzyme that traps vitamin A (all-trans-retinol) from the circulation and photoreceptor cells to produce the esterified substrate for retinoid isomerase (RPE65), which converts all-trans-retinyl ester into 11-cis-retinol. Here we investigated retinylamine and its derivatives to assess their inhibitor/substrate specificities for RPE65 and LRAT, mechanisms of action, potency, retention in the eye, and protection against acute light-induced retinal degeneration in mice. We correlated levels of visual cycle inhibition with retinal protective effects and outlined chemical boundaries for LRAT substrates and RPE65 inhibitors to obtain critical insights into therapeutic properties needed for retinal preservation.
Synthetic Communications | 2006
Zecheng Chen; Andrew S. Kende; Anny-Odile Colson; José L. Méndez-Andino; Frank H. Ebetino; Rod D. Bush; X. Eric Hu
Abstract We have synthesized guanidine‐containing ketopiperazines designed to be conformational mimics of peptidomimetic arginine amides. D‐Allylglycine was converted by an efficient approach to give enantiopure ketopiperazines in which the trans stereochemistry of the C‐substituents resulted from stereospecific enolate alkylation.
Bioorganic & Medicinal Chemistry Letters | 2006
Namal Chithranga Warshakoon; Justin Sheville; Ritu Tiku Bhatt; Wei Ji; José L. Méndez-Andino; Kenneth M. Meyers; Nick Kim; John August Wos; Chrissy Mitchell; Jennifer L. Paris; Beth B. Pinney; Ofer Reizes; X. Eric Hu
Organic Letters | 2002
X. Eric Hu; and Nick K. Kim; Benoit Ledoussal
Bioorganic & Medicinal Chemistry Letters | 2006
Nick Kim; Kenneth M. Meyers; José L. Méndez-Andino; Namal Chithranga Warshakoon; Wei Ji; John August Wos; Anny-Odile Colson; M. Chrissy Mitchell; Jan Richard Davis; Beth B. Pinney; Ofer Reizes; X. Eric Hu
Journal of Medicinal Chemistry | 2003
X. Eric Hu; Nick Kim; Jeffrey Lyle Gray; Ji-In Kim Almstead; William Seibel; Benoit Ledoussal